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Abstract 
We report a case of primary renal lymphoma in a 48-year-old man. He was admitted with 
a large homogenous right renal mass that was revealed by computed tomography scan 
of the abdomen and pelvis. The patient underwent transperitoneal right radical 
nephrectomy. Pathologic diagnosis was in favor of primary renal lymphoma. 
Introduction 
Renal involvement is common in patients with systemic Non-Hodgkin’s lymphoma. 
Primary renal lymphoma (PRL) is a controversial and rare disease. There is no agreement 
whether or not it is an initial manifestation or a rapidly systemic disease. The term PRL is 
applied when the disease is localized to the kidney without any sign of other organ 
involvement or when renal involvement is the presenting manifestation [1]. Flank pain is 
the most common presenting symptom, and different histologies have been reported. 
Case Presentation 
The patient was a 48-year-old Iranian male who was admitted due to dull abdominal pain, anorexia 
and fatigue. The pain began 2 months previously. In the past medical history only controlled 
hypertension was detected. No history of any surgery was present. BMI was 28. Physical examination 
showed a palpable mass in the right flank area. Hematological examination results and biochemistry lab 
data (renal function tests, liver function tests, and other routine lab tests) were within the normal limits, 
whereas urine analysis showed only microscopic hematuria (10–12 RBCs). An ultrasonographic 
examination of the abdomen and pelvis showed a large retroperitoneal mass of the right kidney (fig. 2). 
The contralateral kidney was normal. On the abdominal computed tomography (CT) scan a large  
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homogenous right renal mass (with 17.5 × 13 cm size) was detected. Chest X-ray was within normal 
limits. Due to suspicion of renal cell carcinoma, transperitoneal right radical nephrectomy with 
lymphadenectomy was performed (fig. 3). The weight of the mass was 3,200 g. Pathologic diagnosis was 
in favor of Non-Hodgkin’s PRL (fig. 2). Bone marrow aspiration was done postoperatively, which was 
normal. Systemic chemotherapy with 8 courses of CHOPP regimen (cyclophosphamide, adriamycin, 
vincristine, and prednisone) was initiated without complications. The patient tolerated chemotherapy 
well and is in good physical condition now, one year after surgery. 
Discussion 
Although secondary renal involvement from systemic lymphoma is very frequent, PRL 
is a rare entity, accounting for only 0.7% of all extranodal lymphomas [2], and as a clinical 
entity it is not undisputed because the kidney does not contain lymphatic tissue and the 
mechanism of development of PRL is unclear [3]. It is characterized by aggressive 
histopathology, very early extrarenal infiltration and poor prognosis [4]. PRL is defined as 
a lymphoma that involves only the kidney at presentation and manifests with renal 
involvement [3]. Diagnosis is established by renal biopsy, although it often presents as a 
mass simulating renal cell cancer, and diagnosis is obtained after radical nephrectomy [5]. 
Most PRLs that have been reported were classified as diffuse, large B cell lymphoma, and 
almost all PRLs were of B cell lineage [6]. PRL is a distinct pathological and clinical entity 
which is extremely rare and highly aggressive since disseminating rapidly from its origin. 
Although there are no clearly defined diagnostic criteria for renal lymphomas, abdominal 
and thoracic CT as well as renal and bone marrow biopsy are recommended. The disease 
usually affects adults with an average age of 60 years, and there is a slight male 
preponderance. Several histogenetic theories of the disease have been postulated since the 
kidney does not normally contain lymphoid tissue. The neoplastic lymphoid cells may 
express both B and T immunoblastic phenotypes; primary renal Hodgkin’s lymphoma 
has also been reported. The disease may present with progressive renal failure of either 
oliguric or non-oliguric type. Imaging studies in diagnosing and staging PRL include 
ultrasound examination and CT scanning. Whole body bone scan and bone marrow 
biopsy will complete clinical staging of disease. Renal biopsy is important in assessing the 
diagnosis of PRL. Multidrug chemotherapy is mandatory for high-grade lymphoma and 
when the disease is diagnosed preoperatively. Survival is extremely poor since 75% of 
patients die less than 1 year after operation. Prognosis may be improved by early 
detection of disease and by performing systemic chemotherapy [7]. One of the differential 
diagnoses of PRL is mucosa-associated lymphoid tissue (MALT) lymphoma, which is 
more rare than PRL. MALT lymphoma represents a low-grade B cell marginal zone, the 
lymphoma arising in extranodal tissue in which lymphoid tissues are usually absent, and 
it is usually acquired in response to chronic inflammation or in association with an 
autoimmune disorder. The biological behavior of the disease generally differs from the 
nodal low-grade B cell lymphoma [8] and responds well to local therapy. In a study by 
Schniederjan and Osunkoya [9] on the 40 cases of lymphoid neoplasms of the 
genitourinary tract, the most common site of involvement was the kidney. B cell Non-
Hodgkin’s lymphomas predominated, with diffuse large B cell lymphoma being the most 
common subtype in the entire group. Among renal, bladder, and ureter lymphomas, a 
male predominance was noted (1.6:1). 
Several imaging options exist for evaluation of renal involvement including 
ultrasonography, intravenous pyelography, CT scan, and magnetic resonance imaging 
(MRI). Ultrasonography shows renal lymphoma as a hypoechoic mass, a finding that 
reflects homogeneity. CT scan is the imaging modality of choice for evaluation of the 
kidneys in patients with suspected renal masses including renal lymphoma [6]. The CT  
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patterns in renal lymphoma include: multiple renal masses (with up to 60% of the cases), 
renal invasion from contiguous retroperitoneal disease (seen in 25–30% of cases), solitary 
masses (6% of cases), or diffuse renal infiltration (almost always bilateral and seen in 
approximately 2% of patients) [10]. Solid renal masses including renal cell carcinoma and 
metastases are the most common entities that mimic renal lymphoma at CT [11]. 
Metastases from primary tumors such as breast cancer, lung cancer, or synchronous renal 
cell carcinoma often present as bilateral masses that are indistinguishable from multifocal 
lymphoma, so in such cases, accurate history taking is essential [12]. An infiltrative 
growth pattern may be seen with tumors such as transitional cell carcinoma or with 
inflammatory processes such as xanthogranulomatous pyelonephritis. 
Conclusion 
PRL represents a rare entity which must nevertheless be considered in cases of unusual 
renal masses or otherwise unexplained renal symptoms. Based on our knowledge, this is 
the first case report of PRL from Iran. Standard management of a renal mass is 
nephrectomy. PRL is a rare exception in which renal biopsy is needed for diagnosis. 
Chemotherapy is its first-line therapy and consists of a CHOP regimen associated with 
rituximab. We believe that both the delayed diagnosis and the histological aggressive 
behavior of the disease are responsible for the poor prognosis of PRL and that if 
diagnosed early, cure is possible. 
 
 
 
 
 
Fig. 1. Histologic HE staining of the nephrectomy specimen revealing B cell lymphoma. 
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Fig. 2. Abdominal CT scan revealing a near homogenous mass of the right kidney. 
 
 
 
Fig. 3. Abdominal CT scan, two weeks after operation and before systemic chemotherapy, revealing no 
residual tumor or para-aortic lymph nodes. 
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